Primary adrenal lymphoma and its mimics: clinico-radiological differential diagnosis

原发性肾上腺淋巴瘤及其类似疾病:临床放射学鉴别诊断

阅读:1

Abstract

PURPOSE: Primary adrenal lymphoma (PAL) is a rare malignancy with limited data on its characteristics. It can pose diagnostic challenges in differentiating it from other adrenal masses, such as atypical adrenal adenoma (ADE), pheochromocytoma (PCC), and adrenocortical carcinoma (ACC). This study aimed to characterize patients with PAL and compare their clinical, hormonal, and radiological features with other primary adrenal lesions whose computed tomography characteristics do not match those of a typical adenoma. METHODS: This retrospective, single-center study included four patient cohorts: PAL (n=12), ADE (n=31), PCC (n=18), and ACC (n=19), treated at a tertiary care hospital between January 2013 and January 2024. RESULTS: The histopathological type of all PAL cases was diffuse large B-cell lymphoma (DLBCL). The median age at diagnosis was 70.5 (51-76) years. The diagnosis was more prevalent in males (sex ratio 1.4). Bilateral adrenal involvement was significantly more frequent in PAL patients. Clinical symptoms included general health deterioration (100%), weight loss (75%), abdominal pain (58%) and fever (41.7%). Laboratory assessments showed a higher prevalence of anemia in PAL patients compared to ADE and PCC patients. PAL cases exhibited elevated lactate dehydrogenase (LDH) and β2-microglobulin as well as lipid profile abnormalities. Radiologically, PAL lesions were predominantly homogeneous, with a median tumor size of 78.5 (20-100.5) mm. All lesions exhibited an attenuation value > 20 Hounsfield Unit (HU) and lacked calcifications. Malignant lymph node involvement was significantly more frequent in the PAL than other cohorts. CONCLUSION: PAL should be included in the differential diagnosis of adrenal masses, particularly in cases of bilateral involvement. This study offers insights into its clinical presentation and highlights distinguishing features compared to other primary adrenal malignancies.

特别声明

1、本页面内容包含部分的内容是基于公开信息的合理引用;引用内容仅为补充信息,不代表本站立场。

2、若认为本页面引用内容涉及侵权,请及时与本站联系,我们将第一时间处理。

3、其他媒体/个人如需使用本页面原创内容,需注明“来源:[生知库]”并获得授权;使用引用内容的,需自行联系原作者获得许可。

4、投稿及合作请联系:info@biocloudy.com。